1. Evaluation of the efficacy of azithromycin aerosol fumigation on meibomian gland dysfunction
- Author
-
Jian-Qin Yu, Lu Li, Jie Zhang, Xue-Wen Chen, Jun-Hua Li, and Zu-Hui Zhang
- Subjects
azithromycin ,aerosol fumigation ,meibomian gland dysfunction ,Ophthalmology ,RE1-994 - Abstract
AIM:To evaluate the efficacy and safety of azithromycin aerosol fumigation combined with meibomian gland massage in the treatment of meibomian gland dysfunction(MGD). METHODS: In this prospective study, 47 patients with moderate to severe MGD were treated with azithromycin aerosol fumigation combined with meibomian gland massage. The ocular surface disease index(OSDI)questionnaire, noninvasive tear breakup time(NI-BUT), tear meniscus height and atrophic rate of meibomian glands were recorded at baseline, at 1mo after treatment, and at 3mo after treatment.RESULTS: The OSDI was 21.43±13.14, the first NI-BUT was 9.03±6.09s, the average NI-BUT was 9.72±4.05s, and the tear meniscus height was 0.24±0.09mm after 1mo of treatment. The OSDI was 23.02±11.41, the first NI-BUT was 7.80±4.82s, the average NI-BUT was 10.25±4.78s, and the tear meniscus height was 0.24±0.09mm after 3mo of treatment. Compared with the baseline, the difference was statistically significant(all P0.05). Compared with baseline, there was no significant improvement in atrophic rate of meibomian glands after 1mo of treatment and 3mo after treatment(all P>0.05). In addition, azithromycin aerosol fumigation administration was well tolerated and no adverse reactions were observed during follow-up(all P>0.05). CONCLUSION: Azithromycin aerosol fumigation combined with meibomian gland massage can effectively improve the clinical symptoms and increase first NI-BUT, average NI-BUT, tear meniscus height of patients with moderate to severe MGD.
- Published
- 2021
- Full Text
- View/download PDF